COVID-19肺炎患者的肾脏受累及早期预后
本研究回顾性分析中国单中心333例COVID-19肺炎住院患者,发现75.4%存在尿检异常或AKI,肾脏受累者死亡率11.2%显著高于无肾脏受累者1.2%。肺炎严重程度是与蛋白尿/血尿缓解及AKI恢复关联最强的危险因素。
要点
- COVID-19肺炎患者中75.4%出现肾脏受累(尿检异常或AKI)。
- 肾脏受累者死亡率11.2%,显著高于无肾脏受累者的1.2%。
- 肺炎严重程度是蛋白尿/血尿缓解及AKI恢复的最强负相关因素。
核心结论
- COVID-19肺炎患者中肾脏异常普遍存在,且与更高死亡率相关。
研究设计与样本
- 回顾性单中心研究,纳入中国333例COVID-19肺炎住院患者,分析电子病历中临床、实验室、影像及肾脏结局资料。
主要发现
- 333例中251例(75.4%)出现尿检异常或AKI。
- 198例肾脏受累患者中位持续12天,期间118例(59.6%)肺炎缓解,162例中111例(68.5%)蛋白尿缓解。
- 35例发生AKI(诊断标准较2012 KDIGO定义有所扩展),其中16例(45.7%)肾功能完全恢复。
- 肾脏受累者死亡率28/251(11.2%),无肾脏受累者1/82(1.2%)。
- 逐步多因素二元logistic回归显示肺炎严重程度是与蛋白尿/血尿缓解及AKI恢复负相关最强的危险因素。
临床怎么用
- 对COVID-19肺炎患者应常规监测尿检和肾功能,警惕肾脏受累及高死亡风险。
局限性
- 回顾性单中心设计可能限制结论的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some patients with COVID-19 pneumonia also present with kidney injury, and autopsy findings of patients who died from the illness sometimes show renal damage. However, little is known about the clinical characteristics of kidney-related complications, including hematuria, proteinuria, and AKI. METHODS: In this retrospective, single-center study in China, we analyzed data from electronic medical records of 333 hospitalized patients with COVID-19 pneumonia, including information about clinical, laboratory, radiologic, and other characteristics, as well as information about renal outcomes. RESULTS: We found that 251 of the 333 patients (75.4%) had abnormal urine dipstick tests or AKI. Of 198 patients with renal involvement for the median duration of 12 days, 118 (59.6%) experienced remission of pneumonia during this period, and 111 of 162 (68.5%) patients experienced remission of proteinuria. Among 35 patients who developed AKI (with AKI identified by criteria expanded somewhat beyond the 2012 Kidney Disease: Improving Global Outcomes definition), 16 (45.7%) experienced complete recovery of kidney function. We suspect that most AKI cases were intrinsic AKI. Patients with renal involvement had higher overall mortality compared with those without renal involvement (28 of 251 [11.2%] versus one of 82 [1.2%], respectively). Stepwise multivariate binary logistic regression analyses showed that severity of pneumonia was the risk factor most commonly associated with lower odds of proteinuric or hematuric remission and recovery from AKI. CONCLUSIONS: Renal abnormalities occurred in the majority of patients with COVID-19 pneumonia. Although proteinuria, hematuria, and AKI often resolved in such patients within 3 weeks after the onset of symptoms, renal complications in COVID-19 were associated with higher mortality.
引用
- Pei G, Zhang Z, Peng J, et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020. PMID: 32345702. doi:10.1681/ASN.2020030276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。